MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. - Wikidata - wikimedia - TriplyDB

MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.

MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.

http://www.wikidata.org/entity/Q39016680

about

New Insights into the Crossroads between EMT and Stemness in the Context of Cancer Role of microRNAs in chemoresistance The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells.Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts.MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1 miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells.Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells The role of microRNAs in human breast cancer progression.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.The Role of MicroRNAs in the Chemoresistance of Breast Cancer.MicroRNAs and Cancer Drug Resistance.Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma.Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.Noncoding RNAs in Therapeutic Resistance of Cancer.Approaches for targeting cancer stem cells drug resistance.Involvement of microRNAs in HER2 signaling and trastuzumab treatment.MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.

P2860

Q26764831-BFACABC4-1BCA-4CCC-95BF-8850C6297EBC Q26770485-8AC2C255-DE76-41FF-8473-F5C484893A7A Q26782620-CBAF2381-2E8F-4152-A484-1D6FB36809BD Q26796592-B6ED11DE-C20D-4253-B131-B1FF343A7CA8 Q28070337-18D6177C-1EB7-4D81-8472-750541EF8225 Q33552969-ABCD8B69-A7FC-4169-A3FA-0AEEB0D36DBE Q33618841-E62C92A5-5F28-4CC2-B3B2-AE5860C9EC36 Q35176428-F1FC0D1C-279E-4161-9DCA-5AE93C003BCB Q35550226-E4EEB78D-5854-44D2-B49A-5AC66CEDA316 Q35793883-6AE26D70-B008-48B9-AF2D-371FE729CBE4 Q36089079-57EFB016-04D1-4EF8-9822-7F8DEBE8F306 Q36269777-10FBFFA2-957C-4D99-9D1F-7383B590118C Q36544839-9A39E14D-C941-463B-B456-058A0763035E Q36810185-CDC112DF-BB9E-47A7-A219-8AD5B3EF4AFC Q36955656-4004A7F4-AC1B-480B-BB2C-82FC52B11F9B Q36962950-456AF7CF-900E-4FE6-9935-41E5A3F75913 Q37077423-EAEA57C5-CF22-42D9-8D1B-2BCC7628293A Q37174919-EA162605-539B-4712-9DB7-33E02D18B1D0 Q37271711-9E23137B-B373-443A-9887-F4C0905B2EF4 Q37295569-4D266D0F-C1AF-4621-A8EF-3C8A484668F5 Q37354017-9C879B87-898A-4AE8-9591-0ED146A82BBB Q37588298-AB3474DC-67C5-4CF7-BBD5-F4DACED2360D Q37688154-739C400F-6FF4-4AA0-BEDA-79549D4EC903 Q37709040-27437AE1-0F1F-4ED2-8941-BAC22C88738E Q37716100-E36C9A81-B0AC-47D5-8A71-CA85052DBF2B Q38221040-B1FC77DE-DF24-46A6-A65C-D59197A1648B Q38336073-E7E59C0D-41B0-416A-AAF5-6905293005C9 Q38574546-118D64BE-867E-434C-8D0F-44F725C1E1C4 Q38748118-FC54F6EC-E314-444F-8EAB-0067386A1E89 Q38771232-DA72F885-AF7E-440B-916D-8D5CDB20B2F1 Q38772722-C1C6AE02-112E-4DAD-84AA-A8AC16FFB8B7 Q38788923-A7B23C77-12DB-4DEB-8386-2D443A19E17A Q38874118-637D6D5A-F1FC-4E97-8455-7370AAD1ABE8 Q38885495-43B3A889-3035-473A-8D42-6EB2FE466E55 Q38971795-6B32732B-9F07-4C6A-B140-97D5D9AC9DA2 Q38979308-480E795A-AA41-4798-BC56-A28946331629 Q39145491-06B967A4-D4AB-4356-B0F3-C77AD254995F Q39254523-495A44BC-71BC-4666-9819-02457ACE92A3 Q40616989-2A095866-647D-46FB-8D53-6107C4A69D84 Q42516196-15D0A55D-F427-4DF0-976D-FB9AE55905F2

P2860

MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.

http://www.wikidata.org/entity/Q39016680

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

MiR-200c suppresses TGF-β sign ...... 217 and ZEB1 in breast cancer.

@en

MiR-200c suppresses TGF-β sign ...... 217 and ZEB1 in breast cancer.

@nl

type

label

MiR-200c suppresses TGF-β sign ...... 217 and ZEB1 in breast cancer.

@en

MiR-200c suppresses TGF-β sign ...... 217 and ZEB1 in breast cancer.

@nl

prefLabel

MiR-200c suppresses TGF-β sign ...... 217 and ZEB1 in breast cancer.

@en

MiR-200c suppresses TGF-β sign ...... 217 and ZEB1 in breast cancer.

@nl

P1433

Q39016680-EDCDFAD1-4175-4A89-9FA5-E245E84687F9

P1476

Q39016680-00E33898-C450-40F9-9667-D77CB776A771

P2093

Q39016680-055F25AC-7642-493E-997C-A32ACC7AE16F

Q39016680-32678FED-9C3A-4AA0-AB8A-82AA6107A13F

Q39016680-39C09202-B838-4536-8516-42FB63BCF1BF

Q39016680-7284FDFB-D1EC-4189-96AB-4F69A494C96B

Q39016680-A570BAF9-49DB-43E9-9817-DFA890FDE34F

Q39016680-C7CE12BC-F3B7-4DCD-9159-31CFC4C2C646

Q39016680-C80911D7-37FA-4846-B798-351B9727AD2D

Q39016680-CD51A151-B7F1-4100-97E2-6816D6D0A9B4

Q39016680-D0B335B4-207A-40D5-BA01-D8709E608AF9

Q39016680-F173E450-3B43-44A7-87C2-19C3103968D6

P2860

Q39016680-0443D1B6-40DB-4D26-9A33-ACD708FCBAB1

Q39016680-0FD6AD9C-360D-4314-B166-15157A7777EC

Q39016680-1B317382-195B-42FC-92DB-D85ABD58DCAC

Q39016680-2AB88B9C-A4DE-4EDF-B64F-8CFCCB922951

Q39016680-2C10DCD4-667D-4C94-BB1A-A120572E3146

Q39016680-2C4BC6E2-5E9F-4811-BDC5-9F08C2BA26CD

Q39016680-2CD02E6B-D79A-4AB7-B508-F04BCAC7DD23

Q39016680-2E2B5D80-4B53-4808-962D-4E0A66BF8C87

Q39016680-35C4C6B3-641D-4C16-BEE4-DC1E6F2165D2

Q39016680-3CC6B3A9-CE2E-45FA-860E-31BF4F26A35E

P304

Q39016680-184F5C96-DA8B-49F5-8C20-7CFB9FFD4406

P31

Q39016680-BD89DDE1-2DA2-45D1-B814-ACF188DD90AD

P356

Q39016680-EDE8E5F4-531B-4F95-B302-2216996D2AE5

P433

Q39016680-3718FA29-36E5-4EDA-94FE-D9509312201D

P478

Q39016680-160984CB-C2F5-4100-AFA9-70CD77C85E60

P50

Q39016680-1D5ECD1D-DCCC-4675-9B86-872373BD1D5E

P577

Q39016680-A13742E1-F382-44B5-9187-C082A2A53FF6

P5875

Q39016680-6E46DC56-A898-4766-AB25-4264D2470939

P698

Q39016680-35D0B933-5938-4A8A-B88B-7DB8970FE037

P356

P1433

International Journal of Cancer

P1476

MiR-200c suppresses TGF-β sign ...... 217 and ZEB1 in breast cancer.

@en

P2093

An-Gang Yang

http://www.w3.org/2001/XMLSchema#string

Bin Gu

http://www.w3.org/2001/XMLSchema#string

Guo-Xu Zheng

http://www.w3.org/2001/XMLSchema#string

Hua-Yu Zhu

http://www.w3.org/2001/XMLSchema#string

Jiao Zhao

http://www.w3.org/2001/XMLSchema#string

Meng-Yao Zhang

http://www.w3.org/2001/XMLSchema#string

Wen-Dong Bai

http://www.w3.org/2001/XMLSchema#string

Wen-Jin Xi

http://www.w3.org/2001/XMLSchema#string

Xing-Ming Ye

http://www.w3.org/2001/XMLSchema#string

Xun Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

Epithelial-mesenchymal transitions in development and disease

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

P304

1356-1368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.28782

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260683753

http://www.w3.org/2001/XMLSchema#string

P698

24615544

http://www.w3.org/2001/XMLSchema#string